These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33836992)

  • 21. Audio Interview: Another New Covid-19 Vaccine.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(1):e13. PubMed ID: 34192438
    [No Abstract]   [Full Text] [Related]  

  • 22. The dilemma of herd immunity for COVID-19.
    Nejadghaderi SA; Safiri S
    J Med Virol; 2021 May; 93(5):2578-2579. PubMed ID: 33386744
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 vaccines: resolving deployment challenges.
    Bull World Health Organ; 2021 Mar; 99(3):174-175. PubMed ID: 33716338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
    Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
    [No Abstract]   [Full Text] [Related]  

  • 25. Political Races, Religious Congregations, and Inefficacious Measures Amid the Second Wave of COVID-19 in India.
    Raut AP; Huy NT
    Am J Public Health; 2021 Dec; 111(12):2100-2102. PubMed ID: 34878864
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19: endemic doesn't mean harmless.
    Katzourakis A
    Nature; 2022 Jan; 601(7894):485. PubMed ID: 35075305
    [No Abstract]   [Full Text] [Related]  

  • 27. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

  • 28. How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    Reid M; Abdool-Karim Q; Geng E; Goosby E
    PLoS Med; 2021 Mar; 18(3):e1003564. PubMed ID: 33705396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A call to action for translational sciences in COVID-19 and future pandemics.
    Wan KK; Davis D; Lee TN; Ford-Scheimer SL; Andreu AL; Bietrix F; Bryans J; Castro MT; Chiba N; Faupel-Badger JM; Haynes B; Hirasawa R; Morel CM; Souza TML; Morrow D; Munro T; Newman S; Ussi AE; Zorzal PB; Hall MD; Lo DC; Cutillo CM
    Nat Rev Drug Discov; 2022 Mar; 21(3):165-166. PubMed ID: 35091700
    [No Abstract]   [Full Text] [Related]  

  • 30. Venenum, Virus, Fear, and Politics.
    Bekerman Z
    J Bioeth Inq; 2020 Dec; 17(4):639-642. PubMed ID: 33169250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Nov; 385(19):e78. PubMed ID: 34731543
    [No Abstract]   [Full Text] [Related]  

  • 32. Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
    Beams AB; Bateman R; Adler FR
    Viruses; 2021 May; 13(5):. PubMed ID: 34067128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global South cannot just live with COVID-19.
    Sow SO
    Nat Hum Behav; 2022 Feb; 6(2):170. PubMed ID: 35102354
    [No Abstract]   [Full Text] [Related]  

  • 34. Peruvian COVID-19 vaccine scandal spreads.
    Chauvin L
    Lancet; 2021 Feb; 397(10276):783. PubMed ID: 33640052
    [No Abstract]   [Full Text] [Related]  

  • 35. Global North and South must work hand in glove to stop COVID-19.
    Alakija A
    Nat Hum Behav; 2022 Feb; 6(2):171. PubMed ID: 35102356
    [No Abstract]   [Full Text] [Related]  

  • 36. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    ; ; ;
    Lancet; 2021 Mar; 397(10278):947-950. PubMed ID: 33587888
    [No Abstract]   [Full Text] [Related]  

  • 38. A global health action agenda for the Biden administration.
    Gostin LO; Shalala DE; Hamburg MA; Bloom BR; Koplan JP; Rimer BK; Williams MA
    Lancet; 2021 Jan; 397(10268):5-8. PubMed ID: 33275907
    [No Abstract]   [Full Text] [Related]  

  • 39. Innovation alone won't end COVID-19.
    Amin T
    Nat Hum Behav; 2022 Feb; 6(2):172-173. PubMed ID: 35102360
    [No Abstract]   [Full Text] [Related]  

  • 40. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.